P4HB and plasma cell myeloma: As expected with PDI inhibition and ER stress, treatment with CCF642-34 robustly increased reactive oxygen species (ROS) in myeloma cells, observable within 25 min and peaking between 2–3 h where 4–6-fold increase was detected by carboxy-H2DCFDA (Figure 4C).